Assembly Biosciences, Inc. Stock Analysis & AI Score
Assembly Biosciences, Inc. (ASMB) has an ST Score of 59.4 (B-), driven by its Profitability (A+) and held back by its Momentum (C-). Analysts rate it Buy with a $51.67 price target (+118.4% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Assembly Biosciences, Inc. (ASMB) has an ST Score of 59.4 (B-), driven by its Profitability (A+) and held back by its Momentum (C-). Analysts rate it Buy with a $51.67 price target (+118.4% upside).
- Strongest
- ProfitabilityA+
- Weakest
- MomentumC-
All factor grades
- ProfitabilityA+
- Financial StrengthA
- ForecastA
- GrowthB
- ValuationC-
- MomentumC-
- Piotroski2/9
Contact
ASMB stock: frequently asked questions
What is ASMB's ST Score?
Assembly Biosciences, Inc. (ASMB) has an ST Score of 59.4 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ASMB a buy, hold, or sell?
Analysts rate ASMB a Buy, with a price target of $51.67 (+118.4% vs the current price). Our ST Score grades it B- (59.4/100). The ST Score is a data-driven signal, not a recommendation.
What are ASMB's factor grades?
Valuation C-, Profitability A+, Financial Strength A, Momentum C-, Growth B, Forecast A.
What is ASMB's valuation grade?
Assembly Biosciences, Inc. (ASMB) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ASMB's growth grade?
Assembly Biosciences, Inc. (ASMB) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ASMB's profitability grade?
Assembly Biosciences, Inc. (ASMB) earns a profitability grade of A+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ASMB's financial strength grade?
Assembly Biosciences, Inc. (ASMB) earns a financial strength grade of A, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ASMB?
The average analyst price target for Assembly Biosciences, Inc. (ASMB) is $51.67 from 11 analysts, which is +118.4% versus the recent price of $23.66.
What is ASMB's Piotroski score?
Assembly Biosciences, Inc. (ASMB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.